Researchers are currently experimenting in laboratories on the bioavailability of oral-buccal administration of peptide compared to the subcutaneous route, and results so far show that 1mg of peptide administered sublingually daily is equivalent to 5mg administered subcutaneously weekly. The research aims to suggest alternative methods for alleviating redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population. 

The capsules contain 1mg of filled peptides for research purposes. It is important to note that the FDA has not approved the use of peptides in humans. All peptide products here are strictly for lab use only irrespective of form and shape. You must be 21 years or older to order.